Neoadjuvant Cetuximab Leading to a Complete Pathologic Response in Locally Advanced Lip Squamous Cell Carcinoma

Ruba Alchaikh Hassan, Zahra Gafarzadeh, Shiva Salmasi, David M Hyams, Constantin A Dasanu · 2024

Read Neoadjuvant Cetuximab Leading to a Complete Pathologic Response in Locally Advanced Lip Squamous Cell Carcinoma by Ruba Alchaikh Hassan, Zahra Gafarzadeh, Shiva Salmasi, David M Hyams, Constantin A Dasanu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11693926.txt.

Description

Alchaikh Hassan and co-authors present a 2024 case report on an 81-year-old man with advanced lip cancer. His lower lip squamous cell cancer sat on the vermillion, the red part of the lip. A first immune drug, cemiplimab, failed to shrink it. Doctors then gave cetuximab, an antibody drug, before planned surgery.

After that treatment, removed tissue showed a complete response, with no cancer left under the microscope. The man stayed under watch, with checks of skin and mouth surfaces. At twenty-four weeks he had no sign of return and liked the look of the repair. The authors claim a first for this setting and urge trials.

Catalog record

CREATORRuba Alchaikh Hassan, Zahra Gafarzadeh, Shiva Salmasi, David M Hyams, Constantin A Dasanu
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE14 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11693926

Browse the full library · About the Tower of Babel